Enveric Biosciences, Inc. (ENVB) Stock Ticker
Market factors today
Unlock the full ENVB picture
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
ENVB stock facts
| Ticker symbol | ENVB |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $895,518 |
| CEO | Joseph Edward Tucker |
| Employees | 6 |
| Headquarters | Cambridge, MA, US |
| IPO date | 2015-05-04 |
| Website | www.enveric.com |
What you can see for ENVB on Tickr
Live ENVB price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ENVB report.
Rankings
FAQ
What is the ticker symbol for Enveric Biosciences, Inc.?
The ticker symbol for Enveric Biosciences, Inc. is ENVB, listed on the NASDAQ Capital Market.
What is ENVB?
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication,…